VR-assisted rehabilitation to help COPD patients improve breathing and exercise capacity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial examines the addition of virtual reality to standard pulmonary rehabilitation in adults with chronic respiratory disease, focusing on COPD. Participants undergo a cross-over design to compare outcomes with and without VR during rehabilitation. The study aims to see if VR can reduce exertional symptoms and improve dyspnea and muscle function. Eligible participants are adults with COPD or similar chronic respiratory disease who are in a Paris hospital-based rehabilitation program and can communicate in French. Safety and feasibility will be monitored throughout the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient aged 18 years or older
* Patient with a chronic respiratory disease requiring pulmonary rehabilitation
* Patient with dyspnea assessed as mMRC ≥ 0 (Annex 3)
* Patient undergoing pulmonary rehabilitation at the Paris Saint-Joseph Hospital
* Patient affiliated with a health insurance plan
* French-speaking patient
* Patient who has provided informed, explicit, and voluntary oral consent

Exclusion Criteria:

* Contraindications for an endurance reconditioning program (neurodegenerative diseases, severe neurological deficits, unstable cardiovascular diseases)
* History of motion sickness, vertigo, vestibular impairment, labyrinthitis
* History of seizures or other neurological or psychiatric comorbidities
* Severe visual impairments
* Patient already included in a Type 1 interventional research protocol (RIPH1)
* Patient under guardianship or curatorship
* Patient deprived of liberty
* Patient under legal protection
* Pregnant or breastfeeding patient

Where it's running

• Hôpital Paris Saint Joseph
  Paris, Paris, France Recruiting

Study contacts

• Study coordinator: Johan Wormser
• Email: jwormser@ghpsj.fr
• Phone: 0144123085

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Flutter therapy added to chest physiotherapy after CABG in COPD patients

  This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.

  Recruiting Foundation University Islamabad · Rawalpindi · NCT07875049

• TPB-based cadence exercise and breathing training for COPD patients

  A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.

  Recruiting Fu Jen Catholic University Hospital · New Taipei City, New Taipei City and 1 other locations · NCT07860008

• See how dynamic chest X-rays relate to COPD patterns and progression risk

  This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07762573

• Personalized mobile app warnings to reduce COPD flares

  A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.

  Recruiting at 4 sites Centers for Disease Control and Prevention, China · Beijing and 3 other locations · NCT07656142

• CLEAR model to predict when people with severe COPD can be taken off ventilatory support

  This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.

  Recruiting Assiut University · Asyut, Assuit Egypt · NCT07579052

• Long-term safety of Tozorakimab in COPD patients with prior exacerbations

  This study tests two long-term dosing regimens of tozorakimab in people with COPD who have a history of flare-ups and who completed earlier studies.

  Recruiting at 5 sites Phase 3 AstraZeneca · Aix-en-Provence and 12 other locations · NCT07566195

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.